跳至主要内容
临床试验/NCT02460328
NCT02460328已完成不适用

Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome

Mahidol University1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
age of resolution in immune defect in 22q11.2 Deletion Syndrome

研究概览

简要总结

  • Evaluate about age of resolution in immune defect in 22q11.2 Deletion Syndrome
  • Incidence of immunodeficiencies in 22q11.2 Deletion Syndrome

详细描述

22q11.2 Deletion Syndrome is the most common for microdeletion syndrome. The incidence is about 1:4000 of live birth. Clinical features in this syndrome are vary which consist of conotruncal cardiac anomalies, developmental disabilities, palatal anomalies, speech delay, hypocalcemia, characteristic facial features and immunodeficiencies. The most common type of immunodeficiencies is T cell defect that associated with thymic hypoplasia. In the present time, the investigators don't know about the resolution of immune defect in this syndrome.

研究设计

研究类型
Observational
观察模型
Case Only

入排标准

年龄范围
— 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 22q11.2 deletion syndrome patients in allergy and immunology clinic, genetic clinic, cardio clinic, genetic clinic and development clinic

排除标准

  • loss follow up in 22q11.2 deletion syndrome patients or incomplete medical record

结局指标

主要结局

age of resolution in immune defect in 22q11.2 Deletion Syndrome

时间窗: 18 months

次要结局

  • incidence of immunodeficiencies in 22q11.2 Deletion Syndrome(18 months)
  • type of infectious disease in 22q11.2 Deletion Syndrome(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Resolution of Primary Immune Defect in 22q11.2... | 临床试验